Graham Peter Lidgard
CIK 1216274 · Chief Science Officer · last filed 2021-03-15
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
EXAS price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
MADISON, WI 53719
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| EXACT SCIENCES CORP (EXAS) Delisted | Chief Science Officer | 43,040 | $104.91 | $4.52M | -$50.95M | 58 | 2021-03-15 |
| NGEN | Sr. VP R&D, CTO | 59,618 | $1.39 | $82.6K | $708 | 4 | 2009-01-21 |
Recent Filings · Page 2 of 7
62 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-10-10 | EXACT SCIENCES CORP (EXAS) Delisted | Mixed | −54,428 | -$4.00M | EDGAR |
| 2018-03-15 | EXACT SCIENCES CORP (EXAS) Delisted | Exer (M) | +7,163 | $100.0K | EDGAR |
| 2018-03-13 | EXACT SCIENCES CORP (EXAS) Delisted | Mixed | — | -$613.1K | EDGAR |
| 2018-03-02 | EXACT SCIENCES CORP (EXAS) Delisted | Mixed | −12,647 | -$1.58M | EDGAR |
| 2018-02-28 | EXACT SCIENCES CORP (EXAS) Delisted | Mixed | −7,788 | -$1.36M | EDGAR |
| 2018-02-27 | EXACT SCIENCES CORP (EXAS) Delisted | Mixed | +12,647 | -$670.2K | EDGAR |
| 2017-12-04 | EXACT SCIENCES CORP (EXAS) Delisted | Sell (S) | −45,770 | -$2.67M | EDGAR |
| 2017-11-03 | EXACT SCIENCES CORP (EXAS) Delisted | Sell (S) | −45,775 | -$2.45M | EDGAR |
| 2017-10-03 | EXACT SCIENCES CORP (EXAS) Delisted | Mixed | −45,775 | -$3.33M | EDGAR |
| 2017-09-07 | EXACT SCIENCES CORP (EXAS) Delisted | Mixed | +42,317 | -$1.82M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.